Insufficient scRNA-seq data for expression of UGT1A3 at single-cell level.
Insufficient scRNA-seq data for expression of UGT1A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 98% | 58.08 | 221 / 226 | 40% | 3.19 | 161 / 406 |
kidney | 33% | 1.28 | 29 / 89 | 2% | 0.05 | 22 / 901 |
bladder | 29% | 1.05 | 6 / 21 | 0% | 0.01 | 2 / 504 |
prostate | 7% | 0.22 | 17 / 245 | 12% | 0.52 | 58 / 502 |
intestine | 17% | 1.32 | 167 / 966 | 0% | 0.01 | 2 / 527 |
skin | 13% | 0.39 | 234 / 1809 | 0% | 0 | 0 / 472 |
esophagus | 10% | 0.29 | 141 / 1445 | 1% | 0.01 | 1 / 183 |
stomach | 8% | 0.20 | 27 / 359 | 0% | 0.01 | 1 / 286 |
uterus | 2% | 0.07 | 4 / 170 | 0% | 0.02 | 2 / 459 |
lung | 2% | 0.05 | 10 / 578 | 0% | 0.01 | 4 / 1155 |
peripheral blood | 1% | 0.05 | 12 / 929 | 0% | 0 | 0 / 0 |
breast | 1% | 0.02 | 4 / 459 | 0% | 0.00 | 1 / 1118 |
thymus | 1% | 0.02 | 6 / 653 | 0% | 0 | 0 / 605 |
pancreas | 1% | 0.02 | 3 / 328 | 0% | 0 | 0 / 178 |
adipose | 1% | 0.02 | 9 / 1204 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.02 | 5 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.09 | 1 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.01 | 4 / 1335 | 0% | 0 | 0 / 0 |
brain | 0% | 0.01 | 7 / 2642 | 0% | 0 | 0 / 705 |
heart | 0% | 0.00 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0052697 | Biological process | xenobiotic glucuronidation |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0070640 | Biological process | vitamin D3 metabolic process |
GO_0052696 | Biological process | flavonoid glucuronidation |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0032782 | Biological process | bile acid secretion |
GO_0052695 | Biological process | cellular glucuronidation |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0001972 | Molecular function | retinoic acid binding |
Gene name | UGT1A3 |
Protein name | UDP-glucuronosyltransferase 1A3 (UGT1A3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-3) (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A isoform 3) UDP-glucuronosyltransferase UDP-glucuronosyltransferase (EC 2.4.1.17) UDP-glucuronosyltransferase 1A3 |
Synonyms | GNT1 hCG_2039726 UGT1 |
Description | FUNCTION: [Isoform 1]: UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile . Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds . Catalyzes the glucuronidation of endogenous estrogen hormones such as estradiol and estrone . Contributes to bile acid (BA) detoxification by catalyzing the glucuronidation of BA substrates, which are natural detergents for dietary lipids absorption . Involved in the glucuronidation of calcidiol, which is the major circulating form of vitamin D3, essential for the regulation of calcium and phosphate homeostasis . Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonists losartan, candesartan and zolarsartan, which can inhibit the effect of angiotensin II . .; FUNCTION: [Isoform 2]: Lacks UDP-glucuronosyltransferase (UGT) activity but acts as a negative regulator of isoform 1. . |
Accessions | Q5DT01 A7ISW3 ENST00000482026.6 [P35503-1] A9UKC8 A7E1U6 Q8WX90 A7E1U8 Q8WX89 A7E1U7 A7E1U9 B1MV79 Q8WX91 Q75XT5 Q75XT3 P35503 A7E1U5 A9UKC9 A7E1U4 A9UKD1 |